Drug interactions in hospitalized elderly patients

Objective: To assess the prevalence of drug interactions in elderlyinpatients and to describe the most prevalent interactions. Methods:A retrospective study was conducted in 155 elderly inpatients enrolledin the Clinical Pharmacy program at the elderly-care unit of theHospital Israelita Albert Einst...

Full description

Bibliographic Details
Main Author: Juliana Locatelli
Format: Article
Language:English
Published: Instituto Israelita de Ensino e Pesquisa Albert Einstein 2007-12-01
Series:Einstein (São Paulo)
Subjects:
Online Access:http://www.einstein.br/revista/arquivos/PDF/685-Einstein_P1_Vol5N4_Miolo_Pag.343%20a%20346.pdf
id doaj-6a28f0e8ecda4d23a9242c78d3b8b2e2
record_format Article
spelling doaj-6a28f0e8ecda4d23a9242c78d3b8b2e22020-11-24T21:22:55ZengInstituto Israelita de Ensino e Pesquisa Albert EinsteinEinstein (São Paulo)1679-45082007-12-0154343346Drug interactions in hospitalized elderly patientsJuliana LocatelliObjective: To assess the prevalence of drug interactions in elderlyinpatients and to describe the most prevalent interactions. Methods:A retrospective study was conducted in 155 elderly inpatients enrolledin the Clinical Pharmacy program at the elderly-care unit of theHospital Israelita Albert Einstein from January 2006 to January 2007.Interactions were classified according to severity using Micromedex®.Results: A total of 705 potential drug interactions were found, withapproximately 4 interactions per patient. According to severity, 201(28%) were major severities and 504 (72%) were of moderate severity.Among these 705 interactions, 444 were selected according to theirresulting effect including 161 (36%) had increased risk of bleeding, 78(18%) hypoglycemia or hyperglycemia, 50 (11%) cardiotoxicity, 46(10%) digitalis toxicity, 40 (9%) phenytoin toxicity, 31 (7%) additiverespiratory depression, 20 (5%) hyperkalemia, 18 (4%) decreasedlevothyroxine absorption. Conclusion: The high drug interactionrate found in this study shows the relevance of this issue amongelderly inpatients and the need to assess and monitor drug therapyin the elderly to prevent and reduce consequences of potential druginteraction effects.http://www.einstein.br/revista/arquivos/PDF/685-Einstein_P1_Vol5N4_Miolo_Pag.343%20a%20346.pdfAgedHealth of the elderlyDrug interactionsInpatients
collection DOAJ
language English
format Article
sources DOAJ
author Juliana Locatelli
spellingShingle Juliana Locatelli
Drug interactions in hospitalized elderly patients
Einstein (São Paulo)
Aged
Health of the elderly
Drug interactions
Inpatients
author_facet Juliana Locatelli
author_sort Juliana Locatelli
title Drug interactions in hospitalized elderly patients
title_short Drug interactions in hospitalized elderly patients
title_full Drug interactions in hospitalized elderly patients
title_fullStr Drug interactions in hospitalized elderly patients
title_full_unstemmed Drug interactions in hospitalized elderly patients
title_sort drug interactions in hospitalized elderly patients
publisher Instituto Israelita de Ensino e Pesquisa Albert Einstein
series Einstein (São Paulo)
issn 1679-4508
publishDate 2007-12-01
description Objective: To assess the prevalence of drug interactions in elderlyinpatients and to describe the most prevalent interactions. Methods:A retrospective study was conducted in 155 elderly inpatients enrolledin the Clinical Pharmacy program at the elderly-care unit of theHospital Israelita Albert Einstein from January 2006 to January 2007.Interactions were classified according to severity using Micromedex®.Results: A total of 705 potential drug interactions were found, withapproximately 4 interactions per patient. According to severity, 201(28%) were major severities and 504 (72%) were of moderate severity.Among these 705 interactions, 444 were selected according to theirresulting effect including 161 (36%) had increased risk of bleeding, 78(18%) hypoglycemia or hyperglycemia, 50 (11%) cardiotoxicity, 46(10%) digitalis toxicity, 40 (9%) phenytoin toxicity, 31 (7%) additiverespiratory depression, 20 (5%) hyperkalemia, 18 (4%) decreasedlevothyroxine absorption. Conclusion: The high drug interactionrate found in this study shows the relevance of this issue amongelderly inpatients and the need to assess and monitor drug therapyin the elderly to prevent and reduce consequences of potential druginteraction effects.
topic Aged
Health of the elderly
Drug interactions
Inpatients
url http://www.einstein.br/revista/arquivos/PDF/685-Einstein_P1_Vol5N4_Miolo_Pag.343%20a%20346.pdf
work_keys_str_mv AT julianalocatelli druginteractionsinhospitalizedelderlypatients
_version_ 1725994267581612032